Abstract:Objective To investigate the pathogenic characteristics and preventive measures of bacterial keratitis patients, so as to provide reference for clinical treatment. Methods A total of 52 patients with bacterial keratitis in Hebei Eye Hospital from January 2015 to January 2016 were selected as objects of study. The clinical data were collected. The distribution and drug resistance of pathogenic bacteria were analyzed and the corresponding preventive measures were made. Results From the 52 patients with bacterial keratitis, 21 pathogenic strains were isolated, including 11 strains of Gram-positive cocci accounting for 52.38%, 7 strains of Gram-negative bacilli accounting for 29.41%, 2 strains of Gram-positive bacilli accounting for 9.52%, and 1 strain of Gram-negative cocci accounting for 4.76%. In the Gram-positive cocci, the resistance rates of Staphylococcus aureus to Penicillin G and Imipenem were 100.00% and 80.00% respectively; the drug resistance rates of Staphylococcus epidermidis to Penicillin G, Ampicillin and Imipenem were 100.00%, 66.67% and 66.67% respectively; the resistance rtaes of Streptococcus pneumoniae to Penicillin G and Ampicillin were 100.00%, the resistance rates to Imipenem and Ceftazidime were 50.00%. In the Gram-negative bacilli, the resistance rates of Pseudomonas aeruginosa to Ceftriaxone, Cefuroxime and Cefazolin were 66.67%, and Ampicillin resistance rate reached 100.00%; the resistance rates of Escherichia coli were not less than 50.00%, its resistance rates to Ceftriaxone, Cefuroxime and Ampicillin were 100.00%; the resistance rates of Klebsiella pneumoniae to Ciprofloxacin and Cefazolin were 0.00%. Conclusions There are many types of pathogenic bacteria in the patients with bacterial keratitis. Grampositive cocci and Gram-negative bacilli are the main pathogens. During clinical treatment the dynamic monitoring of pathogens should be further strengthened, pathogen distribution and change trend should be correctly analyzed, antibacterial drugs should be timely adjusted and rationally used according the results of drug sensitive test to further improve the therapeutic effect.